CardiacWire

APRIL 2, 2025

25 saw a deluge of pharmaceutical solutions across the spectrum of heart disease, from HCM all the way to LDL (detection and treatment just have to catch up). Among dozens of highlights, here are Cardiac Wires seven biggest trends from ACC.25. Diverse Pharma ACC.25

Reimbursement 64

Reimbursement TAVR Research Innovation 64

DAIC

MARCH 11, 2024

a med tech company dedicated to helping patients with persistent ischemic heart disease, has announced the treatment of the first patient with the A-FLUX Reducer System, a treatment for patients with angina or chest pain. T45 Labs is a specialized medical technology innovation company located in Santa Clara, Silicon Valley, CA.

Angina 59

Angina Innovation Heart Disease Chest Pain 59

DAIC

JUNE 5, 2024

The sale enhances Edwards’ balance sheet flexibility for disciplined investments in technologies for aortic, mitral, tricuspid and pulmonic patients, as well as new therapeutic areas for interventional heart failure. Critical Care has made significant contributions to our company and has a long history of pioneering innovation.

Critical Care 105

Critical Care Tricuspid Innovation Bicuspid/Mitral 105

DAIC

DECEMBER 27, 2023

The adoption of the latest robotic magnetic navigation system represents our continued commitment to pursuing the innovative technologies and techniques that benefit our patients.” “For

Technology 105

Technology Heart Disease Heart Rhythm Arrhythmia 105

Frontiers in Cardiovascular Medicine

JANUARY 18, 2024

Adipose-derived mesenchymal stem cells (ASCs) represent an innovative candidate to treat ischemic heart disease (IHD) due to their abundance, renewable sources, minor invasiveness to obtain, and no ethical limitations.

Heart Disease 64

Heart Disease Myocardial Infarction Transplant Atherosclerosis 64

Journal of the American Heart Association

JANUARY 16, 2024

Journal of the American Heart Association, Volume 13, Issue 2 , January 16, 2024. BackgroundIdentification of children with latent rheumatic heart disease (RHD) by echocardiography, before onset of symptoms, provides an opportunity to initiate secondary prophylaxis and prevent disease progression.

Bicuspid/Mitral 68

Bicuspid/Mitral Heart Disease Echocardiogram Innovation 68

Frontiers in Cardiovascular Medicine

JANUARY 10, 2024

Background While research on congenital heart disease has been extensively conducted worldwide, comprehensive studies from developing countries and the Arab world remain scarce. Aim This study aims to perform a bibliometric review of research on congenital heart disease in the Arab world from 1997 to 2022.

Congenital Heart Disease 59

Congenital Heart Disease Congenital Research Heart Disease 59

ADN Center of Excellence

NOVEMBER 14, 2024

Access to Cutting-Edge Techniques Many fellowships expose participants to the latest technologies and innovations in their field. These programs also prepare fellows for leadership roles, equipping them to drive change and innovation in their respective fields. When to Pursue a Fellowship? Here are some scenarios to consider: 1.

Academic 59

Academic Interventional Cardiology Private Practice Innovation 59

DAIC

JUNE 13, 2024

It’s a celebration of the amazing innovation that has occurred in structural heart disease therapy over the last 20 years and I’m proud to be part of it. “Andreas Grüntzig was a pioneer in the field, so I’m grateful and honored to receive the Ethica Award,” said Dr. St.

Cardiothoracic 104

Cardiothoracic Interventional Cardiology Bicuspid/Mitral Innovation 104

Medical Xpress - Cardiology

APRIL 7, 2025

The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, in collaboration with researchers across multiple institutions, has published a new study that challenges the long-held belief that high cholesterol correlates and even directly causes coronary artery disease, or plaque buildup in the arteries in metabolically healthy (..)

Cholesterol 43

Cholesterol Research Coronary Artery Disease Diet 43

DAIC

MARCH 19, 2024

Medtronic is proud to support the incoming cohort of dynamic structural heart disease specialists to the CTR REACH program,” said Jeffrey Popma , M.D., vice president and chief medical officer for the Coronary & Renal Denervation business and the Structural Heart & Aortic business at Medtronic.

Research 105

Research Heart Disease Hospital Private Practice 105

Science Daily - Heart Disease

JANUARY 9, 2024

The scientific advance is significant considering pain management is highly relevant to overall wellness for patients with heart, lung, and blood diseases. Such innovation in painless defibrillation and preventing arrhythmia could revolutionize cardiac rhythm management.

Arrhythmia 110

Arrhythmia Defibrillator Innovation 110

DAIC

JUNE 27, 2024

Attendees can join with their peers and participate in sessions on structural heart disease, congenital heart disease, guidelines and trials, AI/Machine learning, technical aspects of cardiac CT, coronary artery disease, vascular heart disease, debates and games and early career topics.

Congenital Heart Disease 105

Congenital Heart Disease Coronary Artery Disease Congenital Heart Disease 105

DAIC

JULY 12, 2024

Lead researcher Dr Pankaj Garg , of the University of East Anglia’s Norwich Medical School and a consultant cardiologist at the Norfolk and Norwich University Hospital, heads up a team of researchers who have pioneered innovative and revolutionary 4D MRI imaging technology.

Outcomes 122

Outcomes Hospital Research Innovation 122

American College of Cardiology

NOVEMBER 5, 2024

The idea that obesity increases the risk of heart failure seems like an obvious conclusion. After all, as the Framingham Heart Study clearly showed, obesity and overweight are significantly associated with a higher risk of hypertension, angina and coronary heart disease.

Heart Failure 43

Heart Failure Innovation Angina Obesity 43

DAIC

JANUARY 31, 2024

Cardiovascular ultrasound has played a key role in the evolution of early diagnosis of structural heart disease, led by a technology pioneered by Philips: the ‘transesophageal echocardiography’ (TEE) ultrasound transducer. TEE helps cardiologists by providing highly detailed images of the heart and its internal structures.

Ultrasound 111

Ultrasound Technology Innovation Heart Valves 111

Circulation: Cardiovascular Interventions

JANUARY 23, 2024

BACKGROUND:Current metrics used to adjust for case mix complexity in congenital cardiac catheterization are becoming outdated due to the introduction of novel procedures, innovative technologies, and expanding patient subgroups. kg at all Congenital Cardiac Catheterization Project on Outcomes participating centers.

Congenital Heart Disease 40

Congenital Heart Disease Congenital Heart Disease Pediatrics 40

DAIC

JANUARY 17, 2024

At present, machine learning, deep learning, and other AI technologies have been tried to be applied to intelligent diagnostic and decision making, image interpretation, accurate classification, and prognostication of cardiovascular diseases, which has led to broad application prospects and innovation potential.

Technology 111

Technology Coronary Artery Disease Cardiovascular Disease Cardiovascular Imaging 111

Circulation

FEBRUARY 19, 2025

Unfortunately, public funding has not kept pace with the burden of disease or rates of inflation. As the nations oldest and largest volunteer organization dedicated to fighting heart disease and stroke, research is critical to the American Heart Associations mission.

Research 84

Research Public Health Innovation Cardiovascular Disease 84

DAIC

JULY 15, 2024

He added, “Adding Story Health to our ecosystem both allows providers to exceed their care quality goals and ensures patients aren’t waiting to receive ongoing care, especially between visits when they may have higher disease burden or complications that can lead to expensive emergency department visits.

Technology 105

Technology Innovation Nursing Heart Failure 105

DAIC

JUNE 4, 2024

This year’s program, “Global Echocardiography: Innovations in Diagnosis and Beyond,” is described as an educational experience gathering global experts and enthusiasts in echocardiography, hosted by the largest global organization for cardiovascular ultrasound imaging serving physicians, sonographers, nurses, and scientists.

Ultrasound 111

Ultrasound Education Research Technology 111

GEMMS

MAY 22, 2024

Advancements in medical technology have revolutionized the diagnosis and treatment of heart diseases, which pose critical chronic conditions that, if left unattended, can have fatal consequences. These algorithms, trained on large datasets, recognize patterns and features associated with heart diseases.

Heart Disease 52

Heart Disease Blood Pressure Technology Innovation 52

DAIC

APRIL 25, 2024

“Until now, there was no available transcatheter treatment options for patients with tricuspid valve disease,” said Robert Kipperman, MD , interventional cardiologist and structural heart disease specialist at Gagnon Cardiovascular Institute’s Valve Center at Morristown Medical Center , part of Atlantic Health System. “We

Tricuspid 111

Tricuspid Quality of Life Hospital Nursing 111

Cardiology Update

JANUARY 7, 2024

Noncoronary topics like structural heart disease and vascular medicine are also addressed. The conference features live demonstrations, training workshops, simulations, clinical cases, late-breaking trials, innovations, and selected scientific abstracts. The course is relevant for the entire heart valve team.

Interventional Cardiology 64

Interventional Cardiology Innovation Heart Disease Physiology 64

Heart 2023 Conference

JANUARY 17, 2024

This institute is dedicated to pioneering research, innovation, and the development of clinically effective techniques for addressing various heart conditions. Additionally, it offers comprehensive cardiac screening and preventive care.

Congenital Heart Disease 49

Congenital Heart Disease Coronary Artery Disease Heart Transplant Transplant 49

DAIC

MARCH 15, 2024

Widely recognized for pioneering innovative concepts and techniques in TAVR, Tang has set contemporary standards in the field. His impressive international academic collaborations include the establishment of multiple global registries and the training of heart teams in structural heart imaging and procedures worldwide.

TAVR 105

TAVR Academic Education Cardiovascular Surgery 105

The New England Journal of Medicine

OCTOBER 29, 2024

The past two decades have witnessed a renaissance in the evaluation and treatment of patients with valvular heart disease, catalyzed by advances in surgical innovation, transcatheter techniques, and multimodality cardiac imaging.

Aortic valve 40

Aortic valve Tricuspid TAVR Aortic 40

DAIC

JANUARY 28, 2025

An improved understanding of heart development could help inform new clinical strategies in managing congenital heart diseases, which are the most common type of birth defects, said research team leader Shang Wang from Stevens Institute of Technology.

Research 52

Research Congenital Technology Congenital Heart Disease 52

MIBHS

JANUARY 31, 2025

Sleep Monitoring Quality sleep is essential for heart health. Wearables that track sleep patterns can identify disruptions, such as sleep apnea, which is a known risk factor for heart disease. By embracing this innovative approach, you can pave the way for a healthier heart and a brighter future.

Heart Rhythm 52

Heart Rhythm Technology AFIB Exercise 52

DAIC

JULY 9, 2024

According to a new analysis published in JACC , the flagship journal of the American College of Cardiology, these counties tend to be more rural and socioeconomically disadvantaged, with a greater burden of cardiovascular disease, thus highlighting deep geographic disparity in access to cardiovascular care. Krumholz, MD, SM, FACC.

Risk Factors 103

Risk Factors Cardiovascular Disease Webinar Public Health 103

DAIC

FEBRUARY 2, 2024

The EVOQUE system is indicated for the improvement of health status in patients with symptomatic severe TR despite optimal medical therapy (OMT), for whom tricuspid valve replacement is deemed appropriate by a heart team.

Tricuspid 100

Tricuspid Quality of Life Bicuspid/Mitral Innovation 100

GEMMS

APRIL 3, 2025

GEMMS is committed to enhancing patient care through innovative solutions that improve engagement, streamline workflows, and support cardiovascular care. In 2025, the demand for telehealth capabilities will only continue to grow, especially in managing chronic conditions like hypertension and heart disease.

Technology 52

Technology Patient Care Education Innovation 52

Cardiometabolic Health Congress

OCTOBER 10, 2024

These innovative companies leverage AI to develop cutting-edge diagnostic tools, predictive analytics, and personalized medicine approaches. These companies are at the forefront of innovation, driving improvements in patient outcomes and reshaping the future of healthcare delivery.

Innovation 52

Innovation Technology Kidney Disease Chronic Disease 52

Science Daily - Heart Disease

MARCH 5, 2025

Researchers have successfully observed early vascular changes in stroke using an innovative photoacoustic technique.

Strokes 52

Strokes Stroke Innovation Research 52

DAIC

FEBRUARY 13, 2024

Cleerly, a digital healthcare company focused on heart disease, has announced continued strong scientific evidence supporting the clinical utility of its products, detailing a study published online on Jan. 25, 2024 in the European Heart Journal Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging. 2023 Dec 12:jead339.

Coronary Artery Disease 103

Coronary Artery Disease Ischemia Atherosclerosis Cardiovascular Imaging 103

ADN Center of Excellence

SEPTEMBER 2, 2024

From advances in pharmacological treatments to innovative procedures like catheter ablation, the landscape of AFib treatment is continually evolving. Rhythm Control: Treatment strategies often focus on either controlling the heart rate or restoring normal rhythm.

AFIB 59

AFIB Atrial Fibrillation Innovation Heart Rhythm 59

DAIC

FEBRUARY 9, 2024

Photo by Cedars-Sinai Raj Makkar, MD , associate director of the Smidt Heart Institute and vice president of Cardiovascular Innovation and Intervention for Cedars-Sinai, was the principal investigator for the TRISCEND II trial at Cedars-Sinai. Moderate and severe tricuspid disease is common in the U.S. Raj Makkar, MD.

Tricuspid 105

Tricuspid Open-Heart Surgery Interventional Cardiology Bicuspid/Mitral 105